Memorial Hospital at Gulfport
Memorial Hospital at Gulfport was paid $286K by Medicaid between Jan 2018 and Nov 2024, across 59 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 53% of everything it billed.
BILOXI, MS 39532
Next to other Internal Medicine Physician providers in Mississippi
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 3,342 | $49K | |
| 2019 | 1,779 | $29K | |
| 2020 | 1,343 | $26K | |
| 2021 | 3,150 | $104K | |
| 2022 | 4,444 | $33K | |
| 2023 | 5,073 | $22K | |
| 2024incomplete | 710 | $24K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 53% | 6,726 | 5,988 | $152K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 4,655 | 3,991 | $77K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.8% | 534 | 470 | $14K |
| 99490 | Ccm add 20min | 3.8% | 1,887 | 1,784 | $11K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.4% | 419 | 383 | $10K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.8% | 373 | 334 | $8K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.8% | 88 | 86 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 141 | 134 | $2K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 73 | 73 | $2K |
| 80053 | Comprehensive metabolic panel | <1% | 475 | 422 | $906.96 |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 123 | 108 | $879.10 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 523 | 460 | $856.34 |
47 more codes
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 129 | $686.93 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 73 | $533.10 |
| 36415 | Collection of venous blood by venipuncture | <1% | 906 | $490.86 |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $345.69 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 157 | $295.37 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 15 | $234.00 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 239 | $196.56 |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 12 | $141.84 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 36 | $86.26 |
| 80061 | Lipid panel | <1% | 203 | $23.22 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 0% | 97 | $0.00 |
| 81003 | 0% | 84 | $0.00 | |
| 84439 | 0% | 64 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 12 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 0% | 71 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 105 | $0.00 |
| 86900 | 0% | 27 | $0.00 | |
| 3078F | 0% | 12 | $0.00 | |
| 82042 | 0% | 13 | $0.00 | |
| 83540 | 0% | 36 | $0.00 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 13 | $0.00 |
| 82570 | 0% | 18 | $0.00 | |
| 86885 | 0% | 28 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 0% | 15 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 178 | $0.00 |
| 86780 | 0% | 56 | $0.00 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 59 | $0.00 |
| 87807 | 0% | 13 | $0.00 | |
| 82728 | 0% | 39 | $0.00 | |
| 82962 | 0% | 13 | $0.00 | |
| 82043 | 0% | 14 | $0.00 | |
| 82607 | 0% | 28 | $0.00 | |
| 87428 | 0% | 169 | $0.00 | |
| 87088 | 0% | 121 | $0.00 | |
| 86901 | 0% | 27 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 12 | $0.00 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 38 | $0.00 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 0% | 88 | $0.00 |
| 81001 | 0% | 30 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 79 | $0.00 |
| 86762 | 0% | 27 | $0.00 | |
| 87340 | 0% | 73 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 13 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 326 | $0.00 |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 12 | $0.00 |
| 83550 | 0% | 14 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Biloxi Hma LLC | Biloxi, MS | $25.71M |
| Memorial Hospital at Gulfport | Gulfport, MS | $6.18M |
| Memorial Hospital at Gulfport | Gulfport, MS | $5.78M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.88M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.71M |
| Memorial Hospital at Gulfport | Wiggins, MS | $1.39M |
| Memorial Hospital at Gulfport | Gulfport, MS | $1.10M |
| Memorial Hospital at Gulfport | Gulfport, MS | $764K |
| Memorial Hospital at Gulfport | Ocean Springs, MS | $736K |
| Memorial Hospital at Gulfport | Gulfport, MS | $482K |
| Memorial Hospital at Gulfport | Gulfport, MS | $205K |
| Memorial Hospital at Gulfport | Gulfport, MS | $143K |
| Memorial Hospital at Gulfport | Long Beach, MS | $115K |
| Memorial Hospital at Gulfport | Wiggins, MS | $78K |
| Memorial Hospital at Gulfport | Diamondhead, MS | $68K |
| Memorial Hospital at Gulfport | Bay St Louis, MS | $64K |
| Memorial Hospital at Gulfport | Diamondhead, MS | $40K |
| Memorial Hospital at Gulfport | Biloxi, MS | $21K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.